TVM Capital is a private equity and venture capital firm established in 1983 and headquartered in Munich, with offices across Europe, the United States, the Middle East and Asia. It provides early-stage through growth investments in life sciences, including biopharma, diagnostics, medtech, digital health, and in information and communications technology spanning software, semiconductors, telecommunications and related services. The firm typically invests between modest seven figures and low tens of millions of euros, often taking majority stakes in portfolio companies and supporting growth to market readiness, licensing, or global expansion. Exits are pursued through initial public offerings or sales to strategic buyers. The firm favors investments in Western markets, with attention to cross-border licenses and international collaboration.

Founded in 1995, SOSV is a global venture capital firm headquartered in New Jersey. It focuses on seed-to-growth stage investments in deep tech innovations, primarily in bio-tech/life sciences and hardware/robotics sectors, with a commitment to human and planetary health.

Established in 2021, Golden Falcon Capital is a venture capital firm headquartered in Wilmington, Delaware. It specializes in investing in technology companies focused on SaaS, infrastructure software, security, fintech, insurtech, commerce, artificial intelligence, analytics, and consumer tech across the United States, Israel, and emerging markets.

Impact Expansion is an impact investing fund manager and growth capital investment firm headquartered in Brussels. It focuses on backing fast-growing companies with high-impact business models in Western Europe, emphasizing education, healthcare, employment and environmental outcomes alongside commercial goals. It pursues buyouts and growth investments to scale operations, aiming to deliver both social impact and financial returns.

Techstart Ventures is a venture capital firm founded in 2014 and based in Belfast, United Kingdom. It acts as a first-cheque investor for extraordinary founders pursuing uncapped global opportunities, focusing on backing early-stage companies at the pre-seed and seed stages.

Shenzhen Capital Group Co., Ltd (SCGC) is a venture capital firm founded in 1999 by the Shenzhen Government. The company is dedicated to fostering national industries, developing national brands, and promoting economic transformation through investments in emerging sectors. SCGC primarily targets small to medium enterprises and innovative high-tech companies, focusing on those in various stages of growth, including startups and those undergoing transformation. Its investment portfolio spans industries that align with national policy support, such as information technology, internet services, new media, biopharmaceuticals, new energy, environmental protection, chemical engineering, and high-end equipment manufacturing. With a registered capital of 5.42 billion RMB and significant assets under management, SCGC has established itself as a leader in the venture capital landscape, having invested in numerous companies, many of which have achieved public listings across global capital markets.

Founded in 2014, eHealth Ventures is a venture capital firm based in Tel Aviv, Israel. It focuses on investing in early-stage digital health companies, particularly those specializing in digital therapeutics and diagnostics.

WI Harper Group is a venture capital firm with cross-border operations in the United States and Greater China. Founded in 1993 and based in San Francisco, the firm maintains a presence in Beijing and Taipei and invests in early and early-expansion stages across the United States, Mainland China, Taiwan and the Asia Pacific. It focuses on technology, healthcare, biotech, artificial intelligence, robotics, fintech, sustainability and new media, supporting portfolio companies from seed through growth rounds and working to help them scale globally through international collaboration.

Hillfarrance is a venture capital investment firm founded in 2019 and based in Auckland, New Zealand. The firm focuses on early-stage investments in the information technology sector, specifically targeting areas such as machine learning, media, gaming, and solutions for climate challenges. Hillfarrance aims to support diverse entrepreneurs who are developing sustainable business models that leverage proprietary data and innovative technologies to gain competitive advantages. The firm is committed to providing honest advice, access to a global network, and fair investment capital to help turn ambitious visions into reality. Named after the founder's ancestral village, Hillfarrance embodies values of openness and community, ensuring that entrepreneurs feel welcomed and supported in their endeavors.

Founded in 2014, Seven Seas Partners is a venture capital firm based in Menlo Park, California. It invests in early growth and growth-stage companies operating in consumer internet, SaaS, Internet of Things (IoT), enterprise cloud infrastructure, and services sectors across the United States and Mainland China.

Founded in 2014, this venture capital firm focuses on early-stage investments in life innovation, green innovation, and platform technology. Based in Osaka, Japan.

Vine Ventures is an early-stage software-focused venture capital firm based in New York. Founded in 2020, it backs early-stage technology companies across the United States, Israel, and Latin America, with a focus on software-enabled businesses with growth potential.

Founded in 2001, Clarendon Fund Managers is a venture capital firm based in Belfast, Ireland. It specializes in investing in small and medium enterprises across various sectors, with a focus on Northern Ireland-based companies offering manufacturing or tradable services. The firm typically invests between £20,000 and £250,000 initially, with the potential for follow-on finance. Clarendon aims to exit its investments within five to seven years.

Founded in 2020, QantX is a venture capital firm headquartered in Bristol, UK. It focuses on investing in innovative startups across various sectors including healthcare, information technology, big data, clean technology, digital health, SaaS, artificial intelligence, climate tech, cybersecurity, HR tech, and IoT, primarily based in England.

Khosla Ventures is a California-based venture capital firm founded in 2004 by Vinod Khosla. It provides capital and strategic guidance to startups across stages, focusing on technology-driven companies in areas such as artificial intelligence, climate and sustainability, enterprise software and services, fintech, digital health, medical technology and diagnostics, therapeutics, consumer products, and frontier technologies. The firm backs bold ventures with the potential to disrupt markets and improve lives, supporting companies from early to growth stages and working closely with entrepreneurs to apply science, technology and innovative business models. While primarily investing in North American technology companies, Khosla Ventures pursues opportunities globally and emphasizes experimentation and impact alongside financial returns. The firm also maintains related impact initiatives that support entrepreneurs addressing socio-economic challenges in emerging markets.

Verge HealthTech Fund, established in 2018 and based in Singapore, is a venture capital firm focused on early-stage investments in global healthcare technology companies. It targets innovative solutions that address disease prevention, management, and health system efficiency, with a particular relevance to emerging Asian markets. The firm seeks and supports visionary founders creating transformative healthtech companies, aiming to foster their growth and scale, regardless of their origin, from Dhaka's streets to Oxford's labs.

Ascension Ventures is a private equity and venture capital firm based in London, United Kingdom, founded in 2012. It focuses on early-stage to growth investments in the United Kingdom, including SEIS and EIS eligible opportunities. The firm targets technology and media driven sectors such as digital media, creative industries, advertising technology, fintech, educational technology, health technology, and next generation platforms, as well as e-commerce, sustainability, energy, transport, and consumer goods. It supports seed to growth rounds and is open to co-investments with angels and other funds, aiming to exit investments in four to seven years. The firm emphasizes building practical partnerships with portfolio companies to foster scale and long-term value.

Ah! Ventures, established in 2009 and headquartered in Mumbai, India, is a prominent platform facilitating early-stage startup fundraising. It connects over 3000 investors, including angels and institutions, with a robust pipeline of 600+ business plans monthly.

Thiel Capital, established in 2011, is a venture capital firm based in West Hollywood, California. It focuses on investments across various industries, including artificial intelligence, drones, and healthcare, at seed, early, and later stages. The firm provides strategic and operational support for Peter Thiel's diverse investment initiatives and entrepreneurial ventures.

Founded in 2023, Empirical Ventures is a venture capital firm based in Bristol, UK. It focuses on investing in innovative life sciences, advanced materials, deep technology, robotics, and automation sectors.

Elevate Capital is a venture capital firm based in Hillsboro, Oregon, established in 2016. It focuses on seed and early-stage investments across the United States, with a regional emphasis on the Pacific Northwest and Portland metro area. The firm targets technology-enabled startups and seeks to diversify founder representation, supporting ventures founded by underrepresented entrepreneurs. Elevate Capital typically participates in early rounds and makes minority investments, providing more than capital through advisory support and access to networks to aid long-term growth. Portfolio scope includes software, life sciences, hardware, consumer products, fintech, healthcare, sustainability, and related technology sectors.

Founded in 2005, Life Science Angels is a prominent angel investor group based in Sunnyvale, California. The firm focuses on investing in healthcare and life sciences companies at seed, early, and later stages.

Established in 2020, the European Innovation Council supports innovative startups and researchers with promising ideas, focusing on early-stage companies with positive environmental, social, or governance impacts. It co-invests alongside private investors.

Desjardins Capital is the private equity and venture capital arm of Mouvement des caisses Desjardins, based in Quebec, Canada. It provides growth capital, mezzanine, and select debt financing to early-stage through mature companies across industrial, manufacturing, technology, and service sectors, with emphasis on health care, life sciences, and biotechnology. The firm also supports cooperatives, including worker-owned and housing cooperatives, and network cooperatives, financing development, acquisitions, expansions, and succession plans. It primarily invests in Quebec and surrounding regions, and can finance growth, acquisitions, management buyouts, and modernization. Investments may be equity or debt, including unsecured loans, with instruments ranging from senior debt to equity, and tenures typically five to eight years for equity and three to five years for debt. The firm often takes minority stakes with board participation. It does not invest in natural resource exploration or financial services. Desjardins Capital traces its roots to 1974 and operates within the Desjardins Group.

Founded in 2004, Atlantic Bridge is a growth equity firm headquartered in Dublin with offices across Europe and the US. It invests in early-stage technology companies, focusing on deep tech sectors such as cybersecurity, cloud computing, AI, and healthtech. The firm's strategy involves helping portfolio companies expand internationally through its global platform.

Furthr VC is the venture capital arm of Furthr, based in Dublin, Ireland. It focuses on early-stage investments in Irish companies that develop B2B software products and medical devices, spanning Seed to Series A rounds, with capital reserved for follow-on investments. The firm emphasizes relationship-driven, founder-centric partnerships and provides hands-on support across strategic areas to accelerate growth, backing born-global Irish software and medtech firms as they scale and pursue subsequent funding rounds.

Founded in 2008, Par Equity is a venture capital firm based in Edinburgh. It focuses on investing in early-stage, high-growth technology companies across Northern England, Northern Ireland, and Scotland.

LUMO Labs is an impact-driven venture capital firm and venture builder based in Eindhoven, Netherlands, with an office in Los Angeles. Founded in 2020, it backs early to growth-stage ventures through a multi-stage investment approach and operates a two-year growth program to accelerate founding teams. It emphasizes technologies such as AI, data, software, hardware, blockchain, robotics, drones, IoT, VR/AR and security, and focuses its portfolio on ventures aiming to solve social challenges. The firm prioritizes sectors including sustainable cities and communities, health and wellbeing, and quality education, offering startups access to capital, expertise, and an expansive network to help scale. By combining investment with hands-on support and collaboration, LUMO Labs seeks to advance startups that deliver measurable social and technological impact.

Holland Capital, established in 1981, is a Dutch private equity firm headquartered in Amsterdam. It specializes in early-stage investments, primarily in the healthcare and technology sectors. The firm manages two active funds: one dedicated to supporting the growth of small and medium-sized enterprises (SMEs) in the Netherlands, and another focused on innovative healthcare businesses. Since its inception, Holland Capital has successfully realized over 115 investments.

Founded in 2012, Joyance Partners is a venture capital firm based in San Francisco. It invests in early-stage companies focused on emerging science and bio-based technologies that empower individuals' health and well-being within two years, as well as startups whose products increase joy, fulfillment, and independence for customers.

Established in 2001, Bullnet Capital is a Madrid-based independent venture capital firm specializing in early-stage investments in technology-oriented projects across Spain. It focuses on software, hardware, and high-value-added services, typically investing between €1 million to €2.5 million per company.

SIG China operates through SIG Asia Investments, a wholly foreign-owned enterprise based in Shanghai with an office in Beijing. The firm focuses on venture capital and private equity investments within China, aiming to deploy proprietary capital in companies operating in the region. As part of the larger Susquehanna International Group, which has over two decades of experience in financial services, SIG China benefits from a robust foundation in trading, market making, and institutional research. The team emphasizes an entrepreneurial approach, leveraging advanced technology and quantitative research to identify and develop investment opportunities. With a commitment to expanding its business in China, SIG Asia Investments plays a pivotal role in fostering growth within the local investment landscape.

Established in 2015, Sunstone Management is a venture capital firm headquartered in Irvine, California. It focuses on investing in early-stage tech companies within the United States.

ShangBay Capital is a California-based venture capital firm founded in 2015 and headquartered in Palo Alto. It focuses on early-stage investments in United States healthcare technology sectors, including life sciences, medical devices, biotechnology, and mobile health. The firm seeks to back companies developing innovative medical technologies and digital health solutions, providing capital and strategic support to help accelerate product development, regulatory pathways, and commercial deployment. By concentrating on early-stage opportunities in health tech, ShangBay Capital aims to partner with founders to advance next-generation healthcare capabilities.

Artesian VC is an alternative investment management company that specializes in early-stage venture capital, particularly in the clean energy sector. Established in 2004 after spinning out from ANZ Banking Group, the company has evolved to manage a range of specialized funds, with a focus on seed and follow-on investments in startups sourced from approved accelerators, incubators, and academic programs. Artesian's investment strategy emphasizes partnerships with leading organizations in the startup ecosystem, enabling it to identify and support high-potential ventures. With offices in Sydney, Melbourne, Shanghai, New York, London, and Singapore, the company has built a global presence and has successfully raised over AUD 255 million for its various funds. Additionally, Artesian has expanded its reach through initiatives like its China VC Fund and plans for a Southeast Asia VC Fund, underscoring its commitment to fostering innovation in diverse markets.

Established in 2002, The FSE Group is a venture capital firm based in Hampshire, UK. It focuses on investing in early-stage and growth-stage startups operating within the renewable energy and social enterprise sectors.

ACF Investors, established in 2011 and based in Sheffield, United Kingdom, operates as a venture capital entity that collaborates with experienced angel investors to support early-stage businesses. The firm focuses on co-investing alongside syndicates of angel investors, leveraging their sector-specific expertise to identify and fund high-potential companies. ACF Investors has built a strong portfolio, having invested over £40 million in partnership with more than £200 million from angel investors and other sources, resulting in a diverse collection of over 80 companies. The organization is dedicated to fostering the growth of small and medium-sized enterprises throughout the UK, often providing support through multiple funding rounds as these companies scale.

Alpha JWC Ventures is an Indonesia-based venture capital firm focused on seed to Series B technology companies in Southeast Asia, with emphasis on fintech, consumer tech, and related sectors. Founded in 2015 and headquartered in Jakarta, it operates across Indonesia and Vietnam, investing in B2B, B2C, media, finance tech, healthcare, and other technology-enabled businesses. The firm takes a long-term, value-adding approach, pursuing disciplined investments and active portfolio management, and partners with institutional investors, strategic institutions, and family offices across Asia, the United States, and Europe. It targets early-stage opportunities in Southeast Asia and seeks to support companies through growth.

Founded in 2014, The Ventures Co. is a venture capital firm based in Seoul, South Korea. It invests in early-stage companies operating in artificial intelligence, mobility, edtech, and biology sectors, providing portfolio companies access to expert support in recruiting, PR, marketing, customer acquisition, fundraising, strategy, engineering, and design.

Founded in 2008, Angelor supports private investors, known as business angels, by providing professional services such as deal sourcing, negotiation, legal structuring, investment tracking, and exit strategy identification. They serve both new and experienced individual or group investors, focusing on French seed and Series A investments in health, environment, and food sectors.

Founded in Lisbon in 2013, Faber is a venture capital firm focusing on early-stage deep tech startups. It invests in innovative companies at the intersection of science and technology, with a specialization in AI/Data, Web3, and Ocean/Climate technologies. Faber's unique approach combines dedicated funds, investment teams, and expert advisors to support founders building global companies.

Par Equity is the venture capital and private equity arm of Scottish Enterprise, headquartered in Edinburgh with an additional office in San Francisco. The firm focuses on early‑stage and growth investments in technology companies and digital health solutions, seeking proprietary technology and proven commercial products ready for transatlantic expansion. It supports Scottish firms aiming to enter the United States and encourages U.S. companies to establish a presence in Scotland, with a particular emphasis on the North of England, Scotland and Northern Ireland. Par Equity typically invests between £250,000 and £1 million, and between £500,000 and £2.5 million, targeting companies with enterprise values up to £10 million.

Maryland Venture Fund, established in 1994 and based in Columbia, Maryland, is an early-stage venture capital firm with a focus on nurturing innovative companies within the state. With a capital base of $110 million, the Fund engages in both direct investments in technology and life sciences, as well as indirect investments in venture capital funds. It typically invests between $0.1 million and $1 million in companies that generate revenues up to $1 million, primarily targeting businesses with fewer than 50 employees that have been operational for no more than five years. The Fund specializes in sectors such as healthcare technology, cybersecurity, and information technology. Investments are structured as equity or convertible debt, and the firm seeks to support companies certified as qualified Maryland cybersecurity entities by the state’s Department of Business and Economic Development.

Kurma Partners is a Paris-based investment firm founded in 2009 that concentrates on financing innovation in healthcare and biotechnology across Europe. It targets early-stage and development capital for companies in life sciences, biotechnology, digital health, and related fields, and emphasizes collaborations with research institutes and hospitals to advance therapies and medical technologies from concept to clinical development. The firm operates as a specialist investor in Europe, supporting ventures that bridge scientific discovery and patient impact through equity investments and strategic guidance.

KittyHawk is a venture capital firm based in Santa Monica, California, founded in 2015. It focuses on leading-edge seed to late-stage pre-IPO companies and supports mission-driven entrepreneurs building world-changing organizations. The firm operates two primary strategies: KittyHawk Frontier, which targets seed-stage investments across frontier technologies such as AI, quantum computing, aerospace, healthcare, longevity, climate, and Web3; and KittyHawk Secondaries, which are pre-IPO secondary funds that leverage relationships with Nasdaq Private Markets to access late-stage opportunities. The firm is led by Will Weisman, a former executive director of Singularity University.

Founded in 2012, Trajectory Ventures is a venture capital firm based in New York. It invests in and collaborates with innovative startups disrupting industries such as AI, data analytics, fintech, ad tech, mobility, aerospace, and infrastructure. The firm employs an 'operators for operators' approach to help portfolio companies scale.

AngelList is a U.S.-based platform founded in 2010, connecting startups with angel investors and job-seekers. It facilitates fundraising, recruitment, and product launches, supporting millions of users worldwide. The company has backed over 20 unicorns and helped launch more than 100,000 products.

Aphelion Capital is a California-based venture capital firm focused on healthcare and technology. It invests in early- and mid-stage medical technology, medical devices, and digital health companies, prioritizing fast-to-market products that are low in capital intensity and that help reduce the cost of delivering quality healthcare. The firm leverages its networks to accelerate commercial success and to support portfolio companies across the United States. Founded in 2005, it operates with a view to building companies from inception through growth.

Founded in 2003, Seraph Group is an investment network specializing in early-stage companies. It provides capital ranging from $50K to $1.5 million and offers a broad value-add network to support entrepreneurs. The group comprises diverse business leaders across various industries, enabling it to evaluate and invest in scalable opportunities across most sectors.

Blackfinch Investments supports financial advisors and ensures its services are accessible to all clients. It focuses on investing in early-stage companies with strong ideas and robust management teams, providing initial and follow-on funding across various sectors. The firm offers long-term assistance and guidance to investee companies to facilitate their success.